- Home
- RAND vs DXR Comparison
RAND vs DXR Comparison
Compare RAND & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- DXR
- Stock Information
- Founded
- RAND 1969
- DXR 1970
- Country
- RAND United States
- DXR United States
- Employees
- RAND N/A
- DXR N/A
- Industry
- RAND Finance: Consumer Services
- DXR Medical/Dental Instruments
- Sector
- RAND Finance
- DXR Health Care
- Exchange
- RAND Nasdaq
- DXR Nasdaq
- Market Cap
- RAND 54.4M
- DXR 46.9M
- IPO Year
- RAND N/A
- DXR N/A
- Fundamental
- Price
- RAND $15.21
- DXR $11.38
- Analyst Decision
- RAND
- DXR Strong Buy
- Analyst Count
- RAND 0
- DXR 1
- Target Price
- RAND N/A
- DXR $25.00
- AVG Volume (30 Days)
- RAND 4.8K
- DXR 7.4K
- Earning Date
- RAND 11-05-2025
- DXR 01-01-0001
- Dividend Yield
- RAND 11.40%
- DXR N/A
- EPS Growth
- RAND N/A
- DXR 3.46
- EPS
- RAND N/A
- DXR 0.36
- Revenue
- RAND $7,966,118.00
- DXR $66,306.00
- Revenue This Year
- RAND N/A
- DXR N/A
- Revenue Next Year
- RAND N/A
- DXR N/A
- P/E Ratio
- RAND N/A
- DXR $32.28
- Revenue Growth
- RAND 1.16
- DXR N/A
- 52 Week Low
- RAND $13.82
- DXR $6.55
- 52 Week High
- RAND $31.89
- DXR $11.70
- Technical
- Relative Strength Index (RSI)
- RAND 46.04
- DXR 56.16
- Support Level
- RAND $14.50
- DXR $11.37
- Resistance Level
- RAND $15.25
- DXR $11.70
- Average True Range (ATR)
- RAND 0.66
- DXR 0.50
- MACD
- RAND 0.03
- DXR -0.01
- Stochastic Oscillator
- RAND 31.70
- DXR 81.18
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.